Skip to main content

Patrick Hall, Robert Cook

Castle Biosciences has appointed Patrick Hall as executive director of medical affairs, and promoted Robert Cook to executive director of research and development. Both are newly created positions. 

Hall, who will oversee Castle Bio's medical affairs strategies and programs, has 27 years of experience in the industry, including 11 years at Genomic Health, most recently as director of genomic science liaisons. Prior to that, he was medical science liaison at Genentech. 

Cook's was previously senior scientist at Castle Bio, which he joined in 2011. He has a Ph.D. from Northwestern University in biochemistry, molecular and cellular biology and did a post-doctoral fellowship at Baylor College of Medicine. Prior to his doctoral degree, he was at Gen-Probe, now part of Hologic.

The Scan

Rise of B.1.617.2 in the UK

According to the Guardian, UK officials expect the B.1.617.2 variant to soon be the dominant version of SARS-CoV-2 there.

Anne Schuchat to Retire

Anne Schuchat is retiring after more than 30 years at the US Centers for Disease Control and Prevention, Politico reports.

US to Share More Vaccines

CNN reports that the US will share 20 million doses of the Moderna, Pfizer, and Johnson & Johnson SARS-CoV-2 vaccines with other countries.

PNAS Papers on Gene Therapy Platform, Aspergillus Metabolome, Undernutrition Model Microbiome

In PNAS this week: approach to deliver protein-based treatments to cells, pan-secondary metabolome of Aspergillus, and more.